These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 300367)
1. Evidence that MuLV-induced thymic lymphoma cells possess specific cell membrane binding sites for MuLV. Baird S; Raschke W; Weissman IL Int J Cancer; 1977 Mar; 19(3):403-13. PubMed ID: 300367 [TBL] [Abstract][Full Text] [Related]
2. Virus-specific T cell response prevents lymphoma development in mice infected by intrathymic inoculation of Moloney leukaemia virus (M-MuLV). Zanovello P; Collavo D; Ronchese F; De Rossi A; Biasi G; Chieco-Bianchi L Immunology; 1984 Jan; 51(1):9-16. PubMed ID: 6228521 [TBL] [Abstract][Full Text] [Related]
3. Moloney murine leukemia virus-induced preleukemic thymic atrophy and enhanced thymocyte apoptosis correlate with disease pathogenicity. Bonzon C; Fan H J Virol; 1999 Mar; 73(3):2434-41. PubMed ID: 9971828 [TBL] [Abstract][Full Text] [Related]
4. Immunological mechanisms in the pathogenesis of virus-induced murine leukemia. I. Autoreactivity. Proffitt MR; Hirsch MS; Gheridian B; McKenzie IF; Black PH Int J Cancer; 1975 Feb; 15(2):221-9. PubMed ID: 1079204 [TBL] [Abstract][Full Text] [Related]
5. Specificity of cell surface virus receptors on radiation leukemia virus and radiation-induced thymic lymphomas. McGrath MS; Decléve A; Lieberman M; Kaplan HS; Weissman IL J Virol; 1978 Dec; 28(3):819-27. PubMed ID: 215782 [TBL] [Abstract][Full Text] [Related]
6. Generation of thymotropic envelope gene recombinant virus and induction of lymphoma by ecotropic Moloney murine leukemia virus. Fischinger PJ; Dunlop NM; Robey WG; Schäfer W Virology; 1985 Apr; 142(1):197-205. PubMed ID: 4060571 [TBL] [Abstract][Full Text] [Related]
7. Effects of nonleukemogenic and wild-type Moloney murine leukemia virus on lymphoid cells in vivo: identification of a preleukemic shift in thymocyte subpopulations. Davis BR; Chandy KG; Brightman BK; Gupta S; Fan H J Virol; 1986 Nov; 60(2):423-30. PubMed ID: 3490580 [TBL] [Abstract][Full Text] [Related]
8. T lymphocyte tolerance and early appearance of virus-induced cell surface antigens in Moloney-murine leukemia virus neonatally injected mice. Collavo D; Zanovello P; Biasi G; Chieco-Bianchi L J Immunol; 1981 Jan; 126(1):187-93. PubMed ID: 6969741 [TBL] [Abstract][Full Text] [Related]
9. Impaired generation of anti-AKR/Gross murine leukemia virus cytotoxic T lymphocytes in mice experimentally infected with MuLV. Coppola MA; Green WR; Rich RF Viral Immunol; 1996; 9(2):107-19. PubMed ID: 8822627 [TBL] [Abstract][Full Text] [Related]
10. In vitro studies of cell-mediated immunity to Moloney murine leukemia virus and Moloney leukemia-associated surface antigens. Ng AK; Ames RS; McIntire RK; Herberman RB Cancer Res; 1979 Dec; 39(12):4887-93. PubMed ID: 387218 [TBL] [Abstract][Full Text] [Related]
11. Endogenous retroviral env expression in primary murine leukemias: lack of xenotropic antigens but presence of distinct mink cell focus-forming env subtypes correlating with ecotropic virus inoculated and mouse strain. Cloyd MW; Evans LH J Natl Cancer Inst; 1987 Jan; 78(1):181-9. PubMed ID: 3025502 [TBL] [Abstract][Full Text] [Related]
12. The G-IX system. A cell surface allo-antigen associated with murine leukemia virus; implications regarding chromosomal integration of the viral genome. Stockert E; Old LJ; Boyse EA J Exp Med; 1971 Jun; 133(6):1334-55. PubMed ID: 5576334 [TBL] [Abstract][Full Text] [Related]
13. Mechanisms of leukemogenesis. I. Generation of autoreactive lymphocytes in response to a murine leukemia virus. Schenk PJ; Howe ML J Immunol; 1979 May; 122(5):1874-80. PubMed ID: 221580 [TBL] [Abstract][Full Text] [Related]
14. G(AKSL2): a new cell surface antigen of the mouse related to the dualtropic mink cell focus-inducing class of murine leukemia virus detected by naturally occurring antibody. Stockert E; DeLeo AB; O'Donnell PV; Obata Y; Old LJ J Exp Med; 1979 Jan; 149(1):200-15. PubMed ID: 216764 [TBL] [Abstract][Full Text] [Related]
15. Different lymphoid cell targets by transformation by replication-competent Moloney and Rauscher mouse leukemia viruses. Reddy EP; Dunn CY; Aaronson SA Cell; 1980 Mar; 19(3):663-9. PubMed ID: 6767548 [TBL] [Abstract][Full Text] [Related]
16. The immune response to Moloney murine leukemia virus-induced tumors: induction of cytolytic T lymphocytes specific for both viral and tumor-associated antigens. Flyer DC; Burakoff SJ; Faller DV J Immunol; 1986 Dec; 137(12):3968-72. PubMed ID: 3491152 [TBL] [Abstract][Full Text] [Related]
18. Immune response to Moloney murine leukemia virus nonviral, tumor-associated antigens fails to provide in vivo tumor protection. Jiang D; Flyer DC J Immunol; 1992 Feb; 148(3):974-80. PubMed ID: 1730885 [TBL] [Abstract][Full Text] [Related]
19. Differential disease restriction of Moloney and Friend murine leukemia viruses by the mouse Rmcf gene is governed by the viral long terminal repeat. Brightman BK; Li QX; Trepp DJ; Fan H J Exp Med; 1991 Aug; 174(2):389-96. PubMed ID: 1856627 [TBL] [Abstract][Full Text] [Related]
20. In vivo antigenic modification of tumor cells. III. Metastatic thymic lymphoma specifically infected by thymotropic retrovirus. Iglehart JD; Weinhold KJ; Huper G; Thiel K; Bolognesi DP J Natl Cancer Inst; 1981 Jul; 67(1):123-30. PubMed ID: 6265678 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]